Monday, January 30, 2023
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
Daily Remedy
  • Home
  • Articles
  • Podcasts
    A conversation with Dr. Selwyn O. Rogers, trauma surgeon and gun policy expert

    A conversation with Dr. Selwyn O. Rogers, trauma surgeon and gun policy expert

    November 25, 2022
    A conversation with Dr. Kyle Fischer, policy director for the Health Alliance for Violence Intervention

    A conversation with Dr. Kyle Fischer, policy director for the Health Alliance for Violence Intervention

    November 25, 2022
    A conversation with Dr. Edwin Leap, physician writer and emergency medicine physician

    A conversation with Dr. Edwin Leap, writer and emergency medicine physician

    November 8, 2022
    A conversation with Mr. Omar M Khateeb, innovator in medical device sales

    A conversation with Mr. Omar M Khateeb, innovator in medical device sales

    October 31, 2022
    A conversation with Miss Smriti Kirubanandan, passionate healthcare strategist

    A conversation with Miss Smriti Kirubanandan, passionate healthcare strategist

    October 23, 2022
    A conversation with Mr. Michael Johnson, legal expert in physician contracts

    A conversation with Mr. Michael Johnson, legal expert in physician contracts

    October 23, 2022
  • Surveys

    Surveys

    Does inflation affect how you use your deductible?

    Does inflation affect how you use your deductible?

    by Jay K Joshi
    December 12, 2022

    Survey Resutls

    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    October 16, 2022
  • About Us
  • Contact us
  • Support Us
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    A conversation with Dr. Selwyn O. Rogers, trauma surgeon and gun policy expert

    A conversation with Dr. Selwyn O. Rogers, trauma surgeon and gun policy expert

    November 25, 2022
    A conversation with Dr. Kyle Fischer, policy director for the Health Alliance for Violence Intervention

    A conversation with Dr. Kyle Fischer, policy director for the Health Alliance for Violence Intervention

    November 25, 2022
    A conversation with Dr. Edwin Leap, physician writer and emergency medicine physician

    A conversation with Dr. Edwin Leap, writer and emergency medicine physician

    November 8, 2022
    A conversation with Mr. Omar M Khateeb, innovator in medical device sales

    A conversation with Mr. Omar M Khateeb, innovator in medical device sales

    October 31, 2022
    A conversation with Miss Smriti Kirubanandan, passionate healthcare strategist

    A conversation with Miss Smriti Kirubanandan, passionate healthcare strategist

    October 23, 2022
    A conversation with Mr. Michael Johnson, legal expert in physician contracts

    A conversation with Mr. Michael Johnson, legal expert in physician contracts

    October 23, 2022
  • Surveys

    Surveys

    Does inflation affect how you use your deductible?

    Does inflation affect how you use your deductible?

    by Jay K Joshi
    December 12, 2022

    Survey Resutls

    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    October 16, 2022
  • About Us
  • Contact us
  • Support Us
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Contrarian

Four the Love of Vaccines

Jay K Joshi by Jay K Joshi
March 20, 2022
in Contrarian
0
Four the Love of Vaccines

A fine line exists between representing public interest and influencing the public. That line has blurred into an interpretive oblivion of late, particularly in the waning days of the pandemic.

Instead of some semblance of closure, we are introduced to a never ending array of buzzwords. Some say the acute phase of the pandemic is over. Some say the pandemic is now endemic. What these words truly mean seem to be subject to the whims of the person speaking, the most important of these coming from Dr. Albert Bourla, the CEO of Pfizer.

“It is necessary”, he responded, when asked on national television whether people will need a fourth dose of a COVID-19 vaccine. “Many variants are coming, and Omicron was the first one that was able to evade – in a skillful way – the immune protection that we’re giving”, he continued, projecting an ominous sense of the unknown in the most genteel of ways. When pressed about the existing levels of protection already afforded from the first three doses he, was conspicuously parse: “The protection we are getting from the third [dose], it is good enough – actually quite good for hospitalizations and deaths [but] not that good against infections [and] doesn’t last very long”.

The interview came on the heels of two events. The first event was met with universal acclaim by the media. Pfizer/BioNTech, as well as Moderna, submitted applications for emergency use authorization of a fourth COVID-19 vaccine for the general public (though it is already available for those with compromised immune systems). The second event, though equally important, went largely unnoticed by the same media outlets.

In January, US District Judge Mark Pittman of the Northern District of Texas ordered the expedited release of all the documents previously submitted by Pfizer/BioNTech for prior emergency use authorization of the initial COVID-19 vaccine. The order took effect in March, just days before Pfizer/BioNTech formally announced its application for a fourth dose.

The two events, when juxtaposed, make for a curious mix that has appeared over and over in the pandemic. COVID-19 is both a viral disease and a disease of perception. And the pandemic was from the beginning, and remains today, a battle on both fronts. It reveals much about how we view our health. For when we receive medical data, we process it differently than we would any other form of information.

Because in healthcare, data is never data alone; it is always data and its interpretation – that together form a narrative. The slew of data coming from the FDA, one from the FOIA request and the other from the fourth emergency use application, will make for an interesting battle of public perception. These narratives will be the basis through which we will determine the need for a fourth dose.

We already see Pfizer/BioNTech charging out the gates. Dr. Bourla, and his accompanying talking-heads, have come out in full support of the fourth dose. They discuss combating the scourge of ‘vaccine hesitancy’, and apparently this new scourge of ‘booster fatigue’. They marvel at the possibility of a ‘panvaccine’, which sounds like a regular vaccine with only the added veneer of a prefix.

The words carry glimpses of a nascent narrative being set – that a fourth vaccine is necessary to give Pfizer/BioNTech and other vaccine developers time to create the perfect COVID-19 vaccine – which we will dutifully take annually, alongside, or possibly in combination with, the annual flu (influenza) vaccine.

Vaccines are undoubtedly a marvel of modern medicine. And the COVID-19 vaccine has doubtlessly saved millions of lives. But there remains a lingering narrative of conspiracy, a fomenting distrust that stains every pandemic related achievement accomplished over the past two years. In this narrative, Pfizer/BioNTech is a greedy pharmaceutical company intent on maximizing profit by skewing data in favor of a fourth dose with the FDA glad-handing in stride.

The February earnings report from Pfizer does little to quell this notion. In it, Dr. Bourla proclaims in no uncertain terms that : “These successes have not only made a positive difference in the world, but I believe they have fundamentally changed Pfizer and its culture forever. Everywhere I look in the company, I see colleagues who are inspired by what we have achieved to date and filled with determination to be part of the next breakthrough that could change the world for patients in need. As we enter a new year, I look forward to all we will accomplish together.”

Such grandiose boasts in earning calls are often accompanied with equally ambitious financial returns. This was no different. Frank D’Amelio, Chief Financial Officer and Executive Vice President of Pfizer, stated: “I am proud to see that the company is performing better than at any other time during my nearly fifteen years here. Today we are issuing guidance for the coming year which, if achieved, would represent the highest level of annual revenues and [earnings per share] in Pfizer’s long history.”

What the word, ‘guidance’, was intended to mean back in February is most apparent today – widespread acceptance of a fourth COVID-19 vaccine. The media appearances indicate much. However, the stronger the narrative for a fourth dose becomes, the stronger the counter-narrative will be – more scrutiny in the data coming from the FOIA request, more questions regarding big pharma’s motivations, and eventually, more distrust in the healthcare system.

This is how healthcare works, and how pandemic polarization has defined the narrative of modern medicine.

The media will set the narrative that we need a fourth dose. The FOIA request, serving as the basis for the counter-narrative, will remain a proverbial gorilla in the room, a thorn in the side of Pfizer/BioNTech and all public health policy experts who advocate for a fourth dose. It will be co-opted to justify conspiracies and to delegitimize normal public discourse on whether a fourth dose is truly needed, regardless of whether the unseal documents even merit such justification.

All because in healthcare, data is never data alone; it is always data and its interpretation. And though we are two years into the pandemic, we still have not learned that we see health in terms of narratives, not data.

But we continue to convince ourselves that we are driven by data when we make health decisions. In that vein, perhaps the problem is not in how the national narrative will be set, but in our inability to recognize our own health.

ShareTweet
Jay K Joshi

Jay K Joshi

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

YouTube Video VVUxUDVQenU5RTFjUVFKNDY2ZlBmdFB3LmdVUm55WVpqRmNn This is a video about Elemental/Essential Frameworks of Healthcare Law

00:00 Elemental/Essential Frameworks of Healthcare Law
Load More... Subscribe

Expert vs. Lay Testimony

Visuals

NADAC (National Average Drug Acquisition Cost)

NADAC (National Average Drug Acquisition Cost)

by Jay K Joshi
January 29, 2023
0

We list the acquisition price of drugs that are covered under the Medicaid Drug Rebate Program - effectively, how much does the government pay for common drugs utilized by patients on Medicaid. Drugs listed are from A-CH.  

Read more

Twitter Updates

Tweets by DailyRemedy1

Newsletter

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do

Popular

  • Letter to the Alabama Board of Medical Examiners

    Letter to the Alabama Board of Medical Examiners

    0 shares
    Share 0 Tweet 0
  • Prosecuting Doctors as Drug Dealers

    0 shares
    Share 0 Tweet 0
  • Why Our Prescribing were for Patients’ Best Interests

    0 shares
    Share 0 Tweet 0
  • Malicious Prosecution and Fabrication of Evidence

    0 shares
    Share 0 Tweet 0
  • My Respect for the Law

    0 shares
    Share 0 Tweet 0

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Newsletter

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2023 Daily Remedy

No Result
View All Result
  • Home
  • Articles
    • Contrarian
    • Financial Markets
    • Innovations & Investing
    • Perspectives
    • Politics & Law
    • Trends
    • Uncertainty & Complexity
  • Podcasts
  • Surveys
    • Survey Results
  • About Us
  • Contact us
  • Support Us

© 2023 Daily Remedy

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do